Zobrazeno 1 - 10
of 117
pro vyhledávání: '"Gurkan U"'
Autor:
AN R., HUANG Y., ROCHELEAU A., AVANAKI A., THOTA P., ZHANG Q., MAN Y., SEKYONDA Z., SEGBEFIA C., DEI-ADOMAKOH Y., MENSAH E., OHENE-FREMPONG K., ODAME I., OWUSU-ANSAH A., GURKAN U.
Publikováno v:
HemaSphere, Vol 6, Pp 16-17 (2022)
Externí odkaz:
https://doaj.org/article/18df3a6757cb4cf0b23946eb7e43d310
Publikováno v:
HemaSphere, Vol 6, Pp 23-24 (2022)
Externí odkaz:
https://doaj.org/article/3205d8920d724b8ca327fbd537f9bc21
Autor:
AN R., MAN Y., CHENG K., ZHANG T., CHEN C., KUCUKAL E., WULFTANGE W., GOREKE U., BODE A., NAYAK L., VERCELLOTTI G., BELCHER J., LITTLE J., GURKAN U.
Publikováno v:
HemaSphere, Vol 6, Pp 19-20 (2022)
Externí odkaz:
https://doaj.org/article/3c3273162fdf450fb04bb1b9895f27a8
Publikováno v:
HemaSphere, Vol 6, Pp 36-37 (2022)
Externí odkaz:
https://doaj.org/article/fc05938fe4c54a2dba43b943a6f3939d
Publikováno v:
HemaSphere, Vol 6, Pp 23-23 (2022)
Externí odkaz:
https://doaj.org/article/42a50ad0184b49e0ad64c19406ba4c24
Autor:
MAN Y., AN R., MONCHAMP K., SEKYONDA Z., FEDERICI C., WULFTANGE W., GOREKE U., BODE A., SHEEHAN V., GURKAN U.
Publikováno v:
HemaSphere, Vol 6, Pp 31-31 (2022)
Externí odkaz:
https://doaj.org/article/78dc9cfeb5d0472d94bf6f02c0d1b73f
Publikováno v:
HemaSphere, Vol 6, Pp 43-43 (2022)
Externí odkaz:
https://doaj.org/article/912767fdcf9041909ed0711013fd0a7f
Autor:
FEDERICI C., KUCUKAL E., KOCEVAR R., GILKEY L., SERTEL S., MONCHAMP K., WOLFE A., NAYAK L., BRUEDERLE A., ZAK J., GURKAN U.
Publikováno v:
HemaSphere, Vol 6, Pp 32-32 (2022)
Externí odkaz:
https://doaj.org/article/b0fc1ab0a8b84244bcd5353de519cdf1
Autor:
Olayiwola, O., Dee, L., Gurkan, U., Bazira, D., Malik, P., Harlow, E., Tisdale, J.F., Mathews, V., Brandon, E., Nsubuga, M.S., Muyanja, D., Orentas, R.J., Deeks, S., Adair, J.E., Mugerwa, H., Dropuli��, B., Popovski, A., Verhoeyen, E., Sheehy, J., Louella, M., Dybul, M., Dub��, K., Bayigga, L., McKemey, A., Kityo, C., Ssali, F., Androski, L., Draz, M.
Publikováno v:
Gene Ther
The gene and cell therapy field saw its first approved treatments in Europe in 2012 and the United States in 2017 and is projected to be at least a $10B USD industry by 2025. Despite this success, a massive gap exists between the companies, clinics,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ff3520c08b344f195fda332e44ed0ec
https://pubmed.ncbi.nlm.nih.gov/34584245
https://pubmed.ncbi.nlm.nih.gov/34584245
Publikováno v:
Journal of Ovarian Research, Vol 17, Iss 1, Pp 1-7 (2024)
Abstract Background An unexpected impaired ovarian response pertains to an insufficient reaction to controlled ovarian hyperstimulation. This deficient reaction is identified by a reduced count of mature follicles and retrieved oocytes during an IVF
Externí odkaz:
https://doaj.org/article/b7f3d9c4c67449d3a51db1b222f0d00a